Globus Medical price target raised to $85 from $70 at Canaccord
The Fly

Globus Medical price target raised to $85 from $70 at Canaccord

Canaccord raised the firm’s price target on Globus Medical (GMED) to $85 from $70 and keeps a Buy rating on the shares. The firm said the company continued its strength from earlier quarters into the Q3 with a significant top- and bottom-line beat driving record FCF and raising of guidance.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App